BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9143683)

  • 1. Naturally occurring primary deficiencies of the immune system.
    Fischer A; Cavazzana-Calvo M; De Saint Basile G; DeVillartay JP; Di Santo JP; Hivroz C; Rieux-Laucat F; Le Deist F
    Annu Rev Immunol; 1997; 15():93-124. PubMed ID: 9143683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary T-cell immunodeficiencies.
    Fischer A
    Curr Opin Immunol; 1993 Aug; 5(4):569-78. PubMed ID: 8216933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
    Chun HJ; Zheng L; Ahmad M; Wang J; Speirs CK; Siegel RM; Dale JK; Puck J; Davis J; Hall CG; Skoda-Smith S; Atkinson TP; Straus SE; Lenardo MJ
    Nature; 2002 Sep; 419(6905):395-9. PubMed ID: 12353035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
    Liston A; Enders A; Siggs OM
    Nat Rev Immunol; 2008 Jul; 8(7):545-58. PubMed ID: 18551129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into lymphocyte development from X-linked immune deficiencies.
    Belmont JW
    Trends Genet; 1995 Mar; 11(3):112-6. PubMed ID: 7732573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiments of nature: primary immune defects deciphered and defeated.
    Smith CI
    Immunol Rev; 2000 Dec; 178():5-7. PubMed ID: 11213807
    [No Abstract]   [Full Text] [Related]  

  • 8. Allogeneic leukocyte and germ cell-induced murine immunodeficiency.
    Raghunathan R; Mundy TM; Faust J; Misra S
    J Immunol; 1985 Oct; 135(4):2429-31. PubMed ID: 3161941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
    Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
    J Immunol; 1983 Jun; 130(6):2635-43. PubMed ID: 6222110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
    Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
    EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
    Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
    J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of proliferation to alloantigen in a sibling of two infants with severe combined immunodeficiency (SCID).
    Spirer Z; Zakuth V; Tzechoval E; Diamant S; Segal S
    Clin Immunol Immunopathol; 1982 Aug; 24(2):286-91. PubMed ID: 6214356
    [No Abstract]   [Full Text] [Related]  

  • 14. Low natural antibody and low in vivo tumor resistance, in xid-bearing B-cell deficient mice.
    Chow DA; Bennet RD
    J Immunol; 1989 May; 142(10):3702-6. PubMed ID: 2785560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic defects in control of T cell activation evolving in a syndrome of lymphohistiocytic activation].
    Dufourcq-Lagelouse R; Pastural E; Barrat FJ; Le Deist F; Fischer A; de Saint Basile G
    Arch Pediatr; 1999; 6 Suppl 2():417s-419s. PubMed ID: 10370555
    [No Abstract]   [Full Text] [Related]  

  • 16. Human primary immunodeficiency diseases.
    Fischer A
    Immunity; 2007 Dec; 27(6):835-45. PubMed ID: 18093537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines and immunodeficiency diseases.
    Leonard WJ
    Nat Rev Immunol; 2001 Dec; 1(3):200-8. PubMed ID: 11905829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic effects of interleukin 2 in primary immunodeficiency diseases.
    Flomenberg N; Welte K; Mertelsmann R; Kernan N; Ciobanu N; Venuta S; Feldman S; Kruger G; Kirkpatrick D; Dupont B; O'Reilly R
    J Immunol; 1983 Jun; 130(6):2644-50. PubMed ID: 6222111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The xid mutation diminishes memory B cell generation but does not affect somatic hypermutation and selection.
    Ridderstad A; Nossal GJ; Tarlinton DM
    J Immunol; 1996 Oct; 157(8):3357-65. PubMed ID: 8871632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in primary immunodeficiency diseases.
    Torgerson TR; Ochs HD
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):515-21. PubMed ID: 17989528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.